Cencora Inc. (COR)vsQuipt Home Medical Corp (QIPT)
COR
Cencora Inc.
$326.91
-1.46%
HEALTHCARE · Cap: $65.11B
QIPT
Quipt Home Medical Corp
$3.65
0.00%
HEALTHCARE · Cap: $162.30M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 122847% more annual revenue ($325.78B vs $264.97M). COR leads profitability with a 50.0% profit margin vs -4.0%. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
QIPT
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-44.0%
Fair Value
$253.90
Current Price
$326.91
$73.01 premium
Intrinsic value data unavailable for QIPT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Revenue surging 32.0% year-over-year
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
Trading at 33.3x book value
Negative free cash flow — burning cash
Smaller company, higher risk/reward
Operating margin of 1.5%
ROE of -9.3% — below average capital efficiency
Earnings declined 97.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bull Case : QIPT
The strongest argument for QIPT centers on Revenue Growth, Price/Book. Revenue growth of 32.0% demonstrates continued momentum.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow. A P/E of 40.2x leaves little room for execution misses.
Bear Case : QIPT
The primary concerns for QIPT are Market Cap, Operating Margin, Return on Equity.
Key Dynamics to Monitor
COR profiles as a mature stock while QIPT is a hypergrowth play — different risk/reward profiles.
COR carries more volatility with a beta of 0.65 — expect wider price swings.
QIPT is growing revenue faster at 32.0% — sustainability is the question.
QIPT generates stronger free cash flow (7M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 40/100), backed by strong 50.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Quipt Home Medical Corp
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?